ArticleImmunity, inflammation and disease2025

RETRACTION: PRMT5 Participates in B Cell Overactivation in Patients With Primary Sjogren's Syndrome (pSS) Through RSAD2-Mediated NF-κB Signaling.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.